Differences in somatic tp53 mutation type in breast tumors by race and receptor status

HIGHLIGHTS

• who: Toland and Amanda from the The Ohio State University The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH, USA have published the research: Differences in Somatic TP53 Mutation Type in Breast Tumors by Race and Receptor Status, in the Journal: (JOURNAL)
• what: The authors aimed to determine if there were differences in somatic TP53 mutation types by patient ancestry or TNBC status. The aim of the study was to determine if the type of TP53 somatic mutation (GOF or LOF, DNE- or DNE+, hotspot status, and CpG nucleotide position) varied in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.